Shanghai Becomes J&J's First Innovation Site Outside North America
By the second quarter of 2019, the doors to a new Johnson & Johnson innovation facility will open in Shanghai, China – the ninth unit to launch under the US giant's JLABS initiative but only the first site outside of North America.
You may also be interested in...
J&J is building its broad presence in Asia Pacific with the opening of an expanded regional hub in Singapore that will pursue R&D partnership, "design-led" health solutions, and human resource development.
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.
The last quarter of 2023 was an exciting one for the cell and gene therapy sector – with the first-ever approval for a CRISPR-based therapeutic in the US and an increase in Phase III trials in the overall CGT pipeline.